EUVIMEDEUVIMED entdecken
LeserbriefKommentarOpen Access

Mitral regurgitation and atrial fibrillation recurrence in hypertrophic cardiomyopathy: association or modifiable substrate?

Teruhiko Imamura

Cardiovascular Diagnosis and Therapy · 2026-06 · 16 (3) · 56-56

DOI: 10.21037/cdt-2026-0229 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Cardiovascular Diagnosis and Therapy, 2026-06. Verfasst von Teruhiko Imamura. Beteiligte Einrichtung: Second Department of Internal Medicine, University of Toyama, Toyama, Japan. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Second Department of Internal Medicine, University of Toyama, Toyama, Japan.

Zitieren

APA

Imamura, T. (2026). Mitral regurgitation and atrial fibrillation recurrence in hypertrophic cardiomyopathy: association or modifiable substrate?. Cardiovascular Diagnosis and Therapy, 16(3), 56-56. https://doi.org/10.21037/cdt-2026-0229

Vancouver

Imamura T. Mitral regurgitation and atrial fibrillation recurrence in hypertrophic cardiomyopathy: association or modifiable substrate?. Cardiovascular Diagnosis and Therapy. 2026;16(3):56-56. doi:10.21037/cdt-2026-0229

BibTeX
@article{Imamura2026,
  author = {Imamura, Teruhiko},
  title = {Mitral regurgitation and atrial fibrillation recurrence in hypertrophic cardiomyopathy: association or modifiable substrate?},
  journal = {Cardiovascular Diagnosis and Therapy},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {56--56},
  doi = {10.21037/cdt-2026-0229}
}
Kostenlos starten →